Recombinant PLAP anticorps (full length)

N° du produit ABIN7878814

Cet anticorps anti-PLAP Monoclonal Lapin (Clone ALPP-8112R) (ABIN7878814) détecte spécifiquement PLAP dans IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant PLAP anticorps (full length) (ABIN7878814)

Antigène: PLAP (ALPP) (Placental Alkaline Phosphatase (ALPP))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp PLAP est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: ALPP-8112R

Détail du produit anti-PLAP anticorps

Épitope: full length

Fonction: Recombinant PLAP Antibody / Placental Alkaline Phosphatase

Purification: Protein A/G affinity

Immunogène: Recombinant full-length human Placental Alkaline Phosphatase protein was used as the immunogen for the recombinant PLAP antibody.

Isotype: IgG, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant PLAP antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant PLAP antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur PLAP

Antigène: PLAP (ALPP) (Placental Alkaline Phosphatase (ALPP))

Autre désignation: PLAP

Sujet: Reacts with a 70 kDa membrane-bound isozyme (Regan and Nagao type) of Placental Alkaline Phosphatase (PLAP) occurring in the placenta during the 3rd trimester of gestation. It is highly specific for PLAP and shows no cross-reaction with other isozymes of alkaline phosphatase. Anti-PLAP reacts with germ cell tumors and can discriminate between these and other neoplasms. Somatic neoplasms e.g. breast, gastrointestinal, prostatic, and urinary cancers may also immunoreact with antibodies to PLAP. Anti-PLAP positivity in conjunction with anti-keratin negativity favors seminoma over carcinoma. Germ cell tumors are usually anti-keratin positive, but they regularly fail to stain with anti-EMA, whereas most carcinomas stain with anti-EMA. Anti-PLAP has been useful in the diagnosis of gestational trophoblastic disease.

UniProt: P05187